메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Miho Nozaki (Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sc) Ian Y Wong (Department of Ophthalmology Hong Kong Sanatorium and Hospital) Ryo Kawasaki (Department of Vision Informatics Osaka University Graduate School of Medicine) Joo Eun Lee (Department of Ophthalmology Haeundae Paik Hospital College of Medicine Inje University) Yoshihiro Takamura (Department of Ophthalmology Faculty of Medical Sciences University of Fukui) Ji Eun Lee (Department of Ophthalmology Pusan National University School of Medicine) Shigeo Yoshida (Department of Ophthalmology Kyushu University) Jae Pil Shin (Department of Ophthalmology Kyungpook National University) Teruyo Kida (Department of Ophthalmology Osaka Medical and Pharmaceutical University) Woohyok Chang (Department of Ophthalmology Yeungnam University College of Medicine) Eiko Tsuiki (Department of Ophthalmology and Visual Sciences Graduate School of Biomedical Sciences Nagasaki Uni) Hidetaka Noma (Department of Ophthalmology Tokyo Medical University Hachioji Medical Center) Kiyoshi Suzuma (Department of Ophthalmology Kagawa University Faculty of Medicine)
저널정보
한국망막학회 Journal of Retina Journal of Retina Vol.7 No.2
발행연도
2022.11
수록면
65 - 74 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: To compare the efficacy of a combination of anti-vascular endothelial growth factor (VEGF) and endpoint management (EpM) grid laser versus monotherapy with anti-VEGF in the management of diabetic macular edema (DME). Methods: This was a prospective, multicenter, open-label, nonrandomized interventional study (NCT02462304). Anti-VEGF therapy consisted of one initial injection administered pro re nata in both groups. EpM laser was performed within 1 month after the first anti-VEGF injection. The main outcome evaluated was the number of anti-VEGF injections performed in 6 months. Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) were also evaluated monthly. The anti-VEGF agent used in Japan and Hong Kong was ranibizumab, while bevacizumab was used in Korea. Results: This study enrolled a total of 42 subjects, with 19 (45.2%) allocated to the monotherapy arm and 23 (54.8%) allocated to the combination arm (EpM group). Overall, there was no significant difference in the number of injections between patients in the two groups (+0.12, p = 0.81). Mixed regression analysis with all the covariates plus an interaction term for the ranibizumab/bevacizumab and the monotherapy/combination arm showed that the EpM group needed 0.94 less injections (95% confidence interval [CI], -1.73 to -0.15; p = 0.02). The logarithm of the minimum angle of resolution BCVA at 24 weeks was significantly improved in the monotherapy arm (p = 0.03), but not in the EpM group (p = 0.09). CFT at 24 weeks was significantly improved in both groups (p < 0.01). Conclusions: These data suggest that combination therapy with the EpM laser may be effective for reducing the number of anti-VEGF injections required for DME treatment.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0